online canadian pharmacy http://www.canadianpharmacy365.net/ pharmacy ratings phentermine no prescription

About

This website is the online repository of all postings from SIGNpost the weekly newsletter of the Safe Injection Global Network.
SIGNpost is a weekly, plain text email newsletter about safe and appropriate use of injections.

Register to comment or to subscribe to the SIGNpost listserve

The  Safe Injection Global Network SIGN is a voluntary coalition of stakeholders aiming to achieve safe and appropriate use of injections throughout the world. The SIGN Internet Forum was established at the initiative of the SIGN secretariat at the World Health Organization’s Essential Health Technologies (EHT) department which provides the secretariat for the network.

For more information, please read the terms of reference of the network at http://www.who.int/injection_safety/sign/en/

A safe injection does not harm the recipient, does not expose the provider to any avoidable risks and does not result in waste that is dangerous for the community

Unsafe injection practices are increasingly recognized as a major source of infection with bloodborne pathogens.

While it is the responsibility of all health care workers, their employers, the public, and national governments to ensure safe and appropriate use of injections, the prevention of bloodborne pathogen transmission and other adverse events associated with injections will require improved collaboration between organizations and individuals sharing a common interest in attaining this goal.

The comments made in SIGNpost or on this website are the sole responsibility of the writers and does not in any way mean that they are endorsed by any of the organizations and agencies to which the authors may belong.

Use of trade names and commercial sources is for identification only and does not imply endorsement.

Selected news items are posted or linked under the fair use doctrine of international copyright law:http://www4.law.cornell.edu/uscode/17/107.html

Contact:   sign.moderator@gmail.com

Comments are closed.